Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil
· Delayed Price · Currency is BRL 10.06
-0.17 (-1.66%)
Apr 28, 2026, 5:07 PM GMT-3
Blau Farmacêutica Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,324 | 2,496 | 2,337 | 2,916 | 4,681 | 6,530 | Upgrade
|
| Market Cap Growth | 4.54% | 6.84% | -19.87% | -37.70% | -28.32% | - | Upgrade
|
| Enterprise Value | 2,292 | 2,715 | 2,442 | 3,041 | 4,231 | 6,028 | Upgrade
|
| Last Close Price | 10.06 | 10.73 | 9.28 | 11.21 | 17.62 | 23.65 | Upgrade
|
| PE Ratio | 7.88 | 8.46 | 10.76 | 11.67 | 12.88 | 20.08 | Upgrade
|
| Forward PE | 7.60 | 8.14 | 8.13 | 12.65 | 11.36 | 15.20 | Upgrade
|
| PS Ratio | 1.36 | 1.47 | 1.33 | 2.12 | 3.33 | 4.78 | Upgrade
|
| PB Ratio | 1.03 | 1.11 | 1.09 | 1.46 | 2.58 | 3.99 | Upgrade
|
| P/TBV Ratio | 1.13 | 1.22 | 1.19 | 1.60 | 2.82 | 4.39 | Upgrade
|
| P/FCF Ratio | 80.67 | 86.67 | 6.41 | 40.99 | 160.06 | 1100.43 | Upgrade
|
| P/OCF Ratio | 7.99 | 8.58 | 4.61 | 13.22 | 27.23 | 42.37 | Upgrade
|
| PEG Ratio | 0.38 | 0.54 | 0.45 | 4.22 | 0.58 | 0.75 | Upgrade
|
| EV/Sales Ratio | 1.35 | 1.60 | 1.39 | 2.22 | 3.01 | 4.41 | Upgrade
|
| EV/EBITDA Ratio | 5.55 | 6.70 | 6.62 | 6.36 | 9.01 | 12.70 | Upgrade
|
| EV/EBIT Ratio | 6.47 | 7.66 | 7.43 | 6.78 | 9.36 | 13.20 | Upgrade
|
| EV/FCF Ratio | 79.56 | 94.27 | 6.70 | 42.74 | 144.69 | 1015.90 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.26 | 0.31 | 0.17 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | 1.45 | 1.45 | 1.49 | 1.26 | 0.66 | 0.79 | Upgrade
|
| Debt / FCF Ratio | 20.80 | 20.80 | 1.53 | 8.55 | 10.66 | 63.11 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.01 | 0.03 | 0.10 | -0.18 | -0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.04 | -0.04 | 0.18 | 0.42 | -0.71 | -1.15 | Upgrade
|
| Net Debt / FCF Ratio | -0.55 | -0.55 | 0.18 | 2.83 | -11.35 | -92.40 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.54 | 0.49 | 0.58 | 0.76 | Upgrade
|
| Inventory Turnover | 1.57 | 1.57 | 1.78 | 1.47 | 1.50 | 1.88 | Upgrade
|
| Quick Ratio | 1.57 | 1.57 | 1.88 | 2.75 | 2.99 | 3.70 | Upgrade
|
| Current Ratio | 2.47 | 2.47 | 3.12 | 4.63 | 4.52 | 4.95 | Upgrade
|
| Return on Equity (ROE) | 13.47% | 13.47% | 10.30% | 12.98% | 20.88% | 34.89% | Upgrade
|
| Return on Assets (ROA) | 6.29% | 6.29% | 6.36% | 10.09% | 11.71% | 15.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.26% | 12.15% | 10.90% | 18.03% | 27.05% | 34.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.40% | 12.40% | 11.40% | 16.50% | 21.30% | 23.00% | Upgrade
|
| Earnings Yield | 12.69% | 11.82% | 9.30% | 8.57% | 7.76% | 4.98% | Upgrade
|
| FCF Yield | 1.24% | 1.15% | 15.60% | 2.44% | 0.63% | 0.09% | Upgrade
|
| Dividend Yield | 3.53% | - | - | 2.63% | 2.81% | - | Upgrade
|
| Payout Ratio | 27.80% | 27.80% | 25.83% | 26.48% | 37.30% | 32.02% | Upgrade
|
| Buyback Yield / Dilution | - | 0.00% | - | 0.08% | 0.87% | -13.84% | Upgrade
|
| Total Shareholder Return | 3.47% | - | - | 2.72% | 3.68% | -13.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.